<DOC>
	<DOCNO>NCT01654341</DOCNO>
	<brief_summary>The MID-Frail STUDY project focus use intervention design improve functional status enhance quality life ( rather traditional treatment glucose- blood pressure- lowering ) act mechanism involve produce frailty progression adverse outcome .</brief_summary>
	<brief_title>Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes</brief_title>
	<detailed_description>Detailed Description : Subjects enrol main study also invite join follow sub-studies : GENEFRAIL : sub-study aim determine polymorphisms several gene associate frailty , order establish predictive value develop disability response treatment well METABOFRAIL : sub-study aim investigate metabolomic profile frail pre-frail patient . SARTRAIN : combination assessment tool use SARTRAIN ( ARFI US , MRI , posturographic measurement ) provide comprehensive study structural functional characteristic muscle adjacent tissue change time intervention . MID- POW : sub-study aim investigate change muscle power . The project also include randomize controlled ancillary study : SENSOLE aim investigate potential effect vibrate insole device gait posture .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion : Participant willing able give write informed consent participation study . Subjects age 70 year old , diagnosis type 2 diabetes mellitus least 2 year . Require fulfill Fried ÃÅs criterion frail prefrail individual . Exclusion criterion : Barthel score low 60 point . Inability carry SPPB test ( total score=0 ) . Mini Mental State Examination score less 20 point . Subjects unwilling unable consent unable participate safely intervention program . Previous history myocardial infarction within 6 month , unstable angina congestive heart failure IIIIV NYHA stage . Clinically instable patient clinical judgment investigator . Terminal illness ( life expectancy &lt; 6 month ) . Any condition , clinical judgment investigator , mean would patient 's best interest enter study . Current participation clinical trial investigational study .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>